Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of THBS4 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of THBS4 mRNA | affects expression | 16483693
|
C015001 |
arsenite |
arsenite results in decreased expression of THBS4 mRNA | decreases expression | 18929588
|
C015001 |
arsenite |
TRP53 protein affects the reaction [arsenite results in decreased expression of THBS4 mRNA] | affects reaction|decreases expression | 18929588
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of THBS4 mRNA | increases expression | 18042831
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of THBS4 mRNA | affects cotreatment|increases expression | 17942748
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of THBS4 mRNA | increases expression | 18035473
|
D005665 |
Furosemide |
Furosemide affects the expression of THBS4 mRNA | affects expression | 16526316
|
C041786 |
palm oil |
palm oil results in increased expression of THBS4 mRNA | increases expression | 18042831
|
D010269 |
Paraquat |
Paraquat results in increased expression of THBS4 mRNA | increases expression | 17275934
|
D013311 |
Streptozocin |
Streptozocin results in increased expression of THBS4 mRNA | increases expression | 16684804
|
D013311 |
Streptozocin |
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of THBS4 mRNA] | decreases reaction|increases expression | 16684804
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of THBS4 mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of THBS4 mRNA | affects cotreatment|increases expression | 17942748
|
C034028 |
vanadyl sulfate |
vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of THBS4 mRNA] | decreases reaction|increases expression | 16684804
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.68 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.08 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.49 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.88 | 11874814 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
10.26 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
10.26 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.71 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.98 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.98 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
5.73 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.77 | 16705839 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18850075 16120746 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.82 | 6135515 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.93 | 17681005 17333356 11677210 16919318 17110522 15861022 16105132 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 16354765 12621046 8697196 15668235 15340226 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.60 | 15037631 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.12 | 18551238 |
MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
4.80 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
9.28 | 15831366 16684804 2177838 8740154 19496084 19960420 1374869 12093613 12083368 15862027 17874149 7637645 19586609 18603373 12446591 15298345 11260395 19298542 18715473 6379147 11055810 12644472 17442507 16286809 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
vanadyl sulfate |
9.28 | 16684804 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
3.65 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
4.71 | 19647726 19586609 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.71 | 17107852 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
5.84 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
4.74 | 19960420 19682444 |
MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
5.52 | 17662242 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.77 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.77 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.51 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Furosemide |
5.07 | 16935035 |
MESH:D004487 |
Edema |
|
Furosemide |
7.37 | 11834646 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.37 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 16714409 18230668 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.28 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
13.67 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
13.67 | 18296743 19004024 17967931 19551842 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.67 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005355 |
Fibrosis |
|
arsenite |
15.48 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
15.48 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
15.48 | 20067830 |
MESH:D005911 |
Gliosis |
|
Paraquat |
5.30 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D034381 |
Hearing Loss |
|
Furosemide |
4.90 | 17868369 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.37 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Streptozocin |
4.33 | 12093613 |
MESH:D006333 |
Heart Failure |
|
Furosemide |
4.11 | 12660669 16011733 16845234 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.00 | 12621046 15340226 16120746 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.88 | 17440010 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 18606429 16959395 15340226 16354765 8697196 |
MESH:D006934 |
Hypercalcemia |
|
Furosemide |
5.15 | 17652376 |
MESH:D053565 |
Hypercalciuria |
|
Furosemide |
5.77 | 17652376 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.67 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.70 | 21332399 |
MESH:D006962 |
Hyperparathyroidism, Secondary |
|
Furosemide |
6.01 | 15086907 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.93 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Furosemide |
5.39 | 16612254 |
MESH:C537153 |
Hypomagnesemia primary |
|
Furosemide |
5.77 | 11041285 |
MESH:D007019 |
Hypoproteinemia |
|
Furosemide |
6.01 | 16096441 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.91 | 16569931 16945680 |
MESH:D007022 |
Hypotension |
|
Furosemide |
4.70 | 11041285 |
MESH:D007024 |
Hypotension, Orthostatic |
|
Furosemide |
5.55 | 15811171 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.55 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.92 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
6.92 | 4850670 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
8.55 | 20412841 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
8.55 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.55 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.15 | 18457598 11836018 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Furosemide |
7.08 | 11041285 |
MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
7.08 | 12093613 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.04 | 16705839 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
7.00 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
7.00 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.46 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.46 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.90 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.90 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
2.50 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.50 | 11884234 19555203 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.08 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.98 | 18551238 7678174 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.53 | 15738583 |
MESH:D009397 |
Nephrocalcinosis |
|
Furosemide |
6.01 | 15086907 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.78 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
MESH:D053206 |
Nocturnal Enuresis |
|
Furosemide |
6.01 | 17945291 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.30 | 18457598 18674790 16723640 21332399 17217161 20132043 19632207 20518802 11836018 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.51 | 16049721 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.77 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.84 | 11124998 15451049 11445065 15824117 16510128 16140633 12911755 11181820 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.53 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.57 | 12504350 |
MESH:D011141 |
Polyuria |
|
Furosemide |
5.77 | 17945291 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.31 | 11222880 11399792 11896295 11118676 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.43 | 15861022 16919318 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.94 | 17997886 16324872 |
MESH:D015427 |
Reperfusion Injury |
|
Furosemide |
3.95 | 16526316 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Furosemide |
9.78 | 16096441 15912074 12394941 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
9.78 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
4.16 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.93 | 16458197 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.59 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.08 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.08 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Furosemide |
2.86 | 17052386 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.71 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.22 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.32 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.43 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.39 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.62 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.81 | 16723640 |